Health & Medicine Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health & Medicine Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Arthritis
CombinatoRx Publishes Clinical Study Results of CRx-102 in Hand Osteoarthritis
November 5th, 2007
CombinatoRx, Incorporated (NASDAQ: CRXX) announced that Annals of the Rheumatic Diseases has published the results of its CRx-102 Phase 2a hand osteoarthritis trial. The manuscript entitled "Efficacy and Safety of a Novel Synergistic Drug Candidate - CRx-102 - in Hand Osteoarthritis", Kvien, et.al. was pre-published on-line and will run in an upcoming print edition. Annals of Rheumatic Diseases is the peer reviewed European League Against Rheumatism (EULAR) journal for rheumatic disease health professionals and researchers. "This study demonstrated that the synergistic combination drug candidate, CRx-102, is effective at reducing...
Source: Health & Medicine Week (2007-11-05)
|
